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Effect of neurokinin-1-receptor 
blockage on fracture healing in rats
Martijn Hofman1, Frederik Rabenschlag1, Hagen Andruszkow1, Julia Andruszkow2, 
Diana Möckel3, Twan Lammers3, Aneta Kolejewska1, Philipp Kobbe1, Johannes Greven1, 
Michel (Paul Johan) Teuben4, Martijn Poeze5 & Frank Hildebrand1
Neurologic injury and selective blockage of sensory nerve endings is associated with impaired fracture 
healing, however, the role of specific neurotransmitters has not been sufficiently investigated. Our 
aim was to investigate the impact of specific Substance P-receptor blockage on fracture healing, since 
the neuropeptide Substance P has both neurogenic and osteogenic activity. After intramedullary 
stabilization, an isolated femur fracture was induced in 72 Sprague-Dawley rats. In the NK1-R group, 
the neurokinin-1-tachykinin receptor for substance P was blocked by a specific antagonist (SR140333) 
for the first two weeks after fracture induction. The control group only received vehicle. Gene-
expression, histology, micro-computed tomography, and biomechanical tests were performed. NK1-
receptor blocking suppressed osteocalcin expression at one week, collagen 1A2 expression at one and 
two weeks and collagen 2A1 expression at 2 weeks after fracture induction. Biomechanical testing 
revealed a significant reduction in maximal load to failure in the NK1-R group at 6 weeks (69.78 vs. 
155.45 N, p = 0.029) and at 3 months (72.50 vs.176.33 N, p = 0.01) of fracture healing. Blocking the NK1-
receptor suppresses gene expression in and reduces biomechanical strength of healing bone. Therefore, 
we assume a potential therapeutic relevance of Substance P in cases of disturbed fracture healing.
Fractures are frequently associated with either central (e.g., traumatic brain injury [TBI]) or peripheral neu-
rological injuries, and these injuries are well known to affect fracture healing. This phenomenon has partly 
been explained by the close anatomical relationship between bones and nerves (e.g., innervation of perios-
teum with close contact between nerve endings and bone cells). It also reflects the chronological association 
between callus formation, bone remodelling, and the regeneration of damaged nerve endings and ingrowth into 
newly formed bone1,2. Disturbances of this re-innervation have therefore been associated with the incidence of 
non-unions3. Hukkanen and colleagues provided the first evidence for a role of nerve-mediated bone forma-
tion in fracture healing by showing that a complete denervation of a leg by sciatic nerve section had negative 
effects on the mechanical integrity of the bony callus after fracture4. Similarly, Offley and colleagues found that 
capsaicin-sensitive neurons contribute to cancellous bone integrity and bone homeostasis in the uninjured bone. 
They concluded that osteoclast numbers, osteoblast activity, bone formation, and bone strength were mediated by 
transmitters released from efferent sensory nerve endings in bone tissue5.
Further, complete peripheral nerve transection6–8 and selective blockade of sensory nerve endings9 can impair 
fracture healing, as demonstrated by previous studies utilizing either combined motoric, sensory, and autonomic 
denervation7,8 or complete sensory nerve ending blockade5,9.
The exact pathophysiologic mechanism underlying this interaction between fracture healing and nerve inju-
ries is not known. Neuropeptides are produced by nerve endings after TBI and fractures, so neuropeptides poten-
tially have major relevance in the process of fracture healing1,2,10,11. However, no precise role has been established 
for specific neuropeptides in bone healing12,13.
One neuropeptide of particular relevance to bone healing is Substance P, which shows simultaneous effects at 
the neurogenic and osteogenic activities. For example, Apel et al. showed that sensory denervation, which shut 
down the transmission of both calcitonin gene-related peptide (CGRP) and Substance P, resulted in an impaired 
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upregulation of collagen I and II in fracture callus and a negative influence on osteoclast function and mechanical 
strength and maturation of fracture callus9. Neurotransmitters were therefore postulated to play a central role in 
the interaction between the nerves and the osseous system8,14, and especially substance P seems to have a signif-
icant involvement in bone metabolism, formation, and resorption, as well as in the osteogenic activity of bone 
marrow stromal cells and osteogenic cell lines15–23. However, the relevance of specific neurotransmitters remains 
unclear in these previous studies. and the specific effects of Substance P on the process of fracture healing have 
not been elucidated. Therefore, the aim of this study was to investigate the effects of specific Substance P-receptor 
blockage on gene expression, callus formation, and the mechanical strength of healing fractures in an isolated 
femur fracture model in rats. We hypothesize that specific substance P receptor blockage impairs mechanical 
strength of healing fractures, decreases gene-expression in the early fracture healing stages and reduces callus 
quantity and quality.
Results
Animal Mortality. At the beginning of the experiments, all animals were in good general health, according 
to the ‘score sheet’ and ‘Body condition scoring’ described in the methods section. No rats died during our study 
due to impacts of the operative procedure or its sequelae. In the course of the experiments, 2 rats (2.78%, planned 
for histological analysis) had to be excluded according to our exclusion criteria; one animal had to be removed 
due to wound dehiscence and the other animal due to anaesthetic complications. In total, this left 70 rats (97.22%) 
for inclusion in the final analyses.
Gene Expression Analysis (Collagen 1A2- and 2A1- and Osteocalcin-mRNA). Osteocalcin expression 
was significantly impaired at 1 week in the NK1-R group compared to the Control group (2.6 ± 0.1 fold vs. 13.5 ± 0.4 
fold, p = 0.0002 for α = 0.05). Collagen 1A2 also showed a significant depression of expression at 1 week (59.5 ± 2.5 fold 
vs. 228.2 ± 33.45 fold, p = 0.00148 for α = 0.05), as well as at the 2-week time point (86.2 ± 7.3 fold vs. 170.3 ± 3.2 fold, 
p = 0.00028 for α = 0.05). Collagen 2A1 expression showed a significant reduction only after 2 weeks (1.9 ± 0.4 fold vs. 
106.9 ± 2.1 fold, p = 0.000041 for α = 0.05) (Fig. 1).
Histological Analysis. The haematoxylin-eosin staining 4 weeks after fracture did not reveal any significant 
differences in terms of vascularity or angiogenesis. The number and diameter of vessels were similar in both 
groups. We performed three microscopical measurements in each animal, but neither in trabecular diameter nor 
in callus diameter significant differences between both study groups were found (Fig. 2).
Micro-CT Scanning. The micro-computed tomography analyses conducted six weeks after fracture induc-
tion showed an almost completed process of ossification and remodelling of the fracture site in the Control 
group, whereas the healing process in the NK1-R group was still in progress, based on the visual analysis of the 
µCT-scanning images, preceding the quantitative computer tomography analyses. In the quantitative computer 
tomography analyses, six weeks after healing, the total bone volume did not significantly differ between the frac-
tured side with callus formation and the unfractured side without callus formation in both study groups. This 
implies that the comparability of the two study groups is warranted. The bone density was significantly lower 
for the fractured femur compared to the femur on the unfractured side in both groups (NK1-R group, p < 0.01; 
Control group, p < 0.05). Furthermore, a significant difference was noted in the transverse diameter between the 
fractured side (callus) and the unfractured side in both groups (NK1-R group, p < 0.01; Control group, p < 0.005). 
No significant differences were observed between the Control and the NK1-R groups (Fig. 3).
The callus formation analysis did not reveal any significant differences between the two groups in terms of the 
volume, diameter, length, or density of the callus (Fig. 3).
Biomechanical tests. Both study groups demonstrated a decreased load to failure of the fractured femora 
compared to the unfractured side at 6 weeks and 3 months after fracture. By contrast, biomechanical analy-
ses at 6 weeks (Control group 251.84 ± 8.87 N vs. NK1-R group 254.48 ± 9.95 N) and 3 months (Control group 
247.00 ± 28.66 N and NK1-R group 224.67 ± 19.10 N) after fracture showed no significant differences in the load 
to failure for the unfractured side in both groups. The fractured side showed a significant (p = 0.029) difference 
in the load to failure between the NK1-R group (69.78 ± 8.51 N) and the Control group (155.45 ± 9.32 N) after 
6 weeks. This difference was even greater at 3 months after fracture (NK1-R group: 72.50 ± 12.09 N vs. Control 
group: 176.33 ± 13.44 N, p = 0.010) (Fig. 4).
Summary of study results. Our main results can be summarized as follows:
 (1) Blocking of the NK1-receptor for Substance P was associated with a reduced expression of different oste-
ogenic proteins (osteocalcin, collagen 1A2, and collagen 2A1) in the early phase (the first two weeks) of 
fracture healing.
 (2) NK1-receptor blocking impaired the normal improvement in biomechanical strength of the bone in the 
late phase (6 weeks and 3 months) after fracture.
 (3) Since the quantitative callus extensions showed no significant differences, but the biomechanical strength 
of the healing bone was impaired, NK1-receptor blocking decreased the quality of the callus formed.
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Discussion
Fracture healing is well recognized as a complex process that is still not completely understood. However, the 
relationship between fracture healing and neurologic injury is well described and implies an influence of neuro-
logical neurotransmitters12,13. Among the various neurotransmitters, Substance P in particular is believed to play 
a central role in bone metabolism. In this context, Substance P has been shown to stimulate bone formation by 
osteoblastic cells through interaction with the NK1-receptor24, whereas blockage of the NK1-receptor enhanced 
widespread osteoporotic processes18. In the present study, our aim was to investigate what influence blocking the 
NK1-receptor for substance P might have on fracture healing.
The important role of Substance P in bone metabolism was especially supported in the present study by the 
demonstration, for the first time, that selective blockage of Substance P activity by a NK1-receptor antagonist 
impairs the gene expression, biomechanical strength, and callus quality of a healing fracture.
The decreased gene expression observed in the present study for osteocalcin, collagen 1A2, and collagen 2A1 
in the early phase of callus formation after Substance P receptor blockade underscores the relevance of Substance 
P in fracture healing. These results are in line with previous RT-PCR studies that showed a similarly impaired 
expression of osteocalcin and collagen during fracture healing in tachykinin-deficient mice15, in sensory dener-
vated rats9, and in rat osteoblastic cells24.
Figure 1. Comparison of fold changes in gene expression. The fold changes of osteocalcin (a), collagen 1A2 
(b), and collagen 2A1 (c) mRNA expression were determined by the reverse transcription polymerase chain 
reaction (RT-PCR) at 3 days, 1 week, and 2 weeks after fracture induction.
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However, beside this role in early fracture healing, Substance P seems also to have relevance for the later 
stages of fracture healing and remodelling of bone. In this context, we were able to show an association between 
NK1-receptor blockade in the first two weeks of fracture healing and a significant decrease in bone strength 
at 6 weeks and even at 3 months after fracture. In previous studies, Niedermair and colleagues showed that 
tachykinin-1-deficient mice (Substance P knockout mice) have a reduced mechanical strength of callus after 3 
weeks of fracture healing, while Apel and colleagues showed that sensory denervated rats have a reduced mechan-
ical strength of callus after 6 weeks of fracture healing9,15. However, none of these studies analysed the biome-
chanical strength at the end of the remodelling phase, as we did after 3 months. If these effects of NK1-receptor 
blockage are exerted in the remodelling phase or are a result based on the earlier effects of NK1-receptor blockage 
on fracture healing has to be explored in future studies.
Contrary to the results presented by Apel and colleagues, our findings did not indicate any significant histo-
logical differences in trabecular or callus diameter. We also did not find any significant radiological differences 
in quantitative callus dimensions in the µCT-analyses between our two study groups, although Apel and col-
leagues did report significant radiological differences. Our results agree with the observations of Niedermair and 
colleagues, who found no radiological differences in callus dimensions between tachykinin-deficient mice and 
a control group15. These comparable quantitative callus dimensions between our study groups, in combination 
with the decrease in biomechanical strength of the bone in the NK1-R group, can only occur if the blockage of 
the NK1-receptor for Substance P impairs the quality of the soft and hard callus formed, although we could not 
substantiate this presumption with histological proof. In this context, the quality of callus is determined by the 
biomechanical strength of the callus and later of the remodelled bone, because the objective of fracture healing is 
to restore the original strength of the bone. Since Apel and colleagues performed a denervation that blocked both 
CGRP and Substance P, this might indicate that CGRP has a greater influence on the amount of callus formed, 
while Substance P regulates the strength and quality of callus.
The findings presented here demonstrate the indispensability of Substance P for normal and appropriate callus 
formation and fracture healing. Nevertheless, clarifying the exact role of Substance P in fracture healing and bone 
formation will require further research. Additional research is also required to assess previously postulated mech-
anisms of action. For instance, Niedermair and colleagues proposed crucial trophic effects of neurotransmitters 
on bone healing via an endogenous callus signalling loop in which chondrocytes producing Substance P and its 
NK1-receptor play an important role15. They consider that the absence of Substance P results in a net decrease in 
bone formation, leading to the observed decrease in the quality of the callus.
Another interesting theory introduced by Davis and colleagues assumed that bone morphogenetic proteins 
(BMPs) released at the fracture site enter peripheral neurons through the damaged blood–nerve barrier. There, 
they induce a neuroinflammation with a release of substance P, as well as a subsequent release of osteoprogenitor 
cells in cases of heterotopic ossifications25. The results of our study could also point to a possible lead for further 
research into enhanced fracture healing in patients with concomitant TBI13,26–28, because Substance P is released 
early following acute injury to the CNS. This promotes a neurogenic inflammatory response that is characterized 
by an increase in the permeability of the blood–brain barrier29
Our study also has some limitations. As our findings were derived from an animal model, they are not directly 
translatable to humans. We chose a rat model because the blockage of a neurotransmitter can only be performed 
in laboratory animals and because adequate blockage of the substance P-receptor with the NK1-receptor antago-
nist SR140333 has been previously demonstrated in this species30. Furthermore, the fracture model in rats is well 
Figure 2. Microscopic imaging of callus tissue. Callus tissue (arrows) between muscle cells (above) and 
bone (below) in control group (a; calibration = 500 µm) and NK1-R group (b; calibration = 500 µm) in 
5× magnification using haematoxylin-eosin staining. Callus tissue in control group (c; calibration = 100 µm) 
and NK1-R group (d; calibration = 100 µm) in 20× magnification using haematoxylin-eosin staining.
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Figure 3. Micro-CT imaging shows the process of ossification and remodelling of the fracture site in the 
control group and NK1-R group. Micro-CT-imaging of the unfractured control left femur as 2D cross-sectional 
image in sagittal plane as well as 3D volume renderings resulting in a spatial resolution of 35 µm voxel side 
length before (a) and after segmentation of the bone (blue) (b); micro-CT-imaging of the fractured right femur 
as 2D cross-sectional image in sagittal plane as well as 3D volume renderings resulting in a spatial resolution of 
35 µm voxel side length before (c) and after segmentation of the bone (blue), callus (green) and K-Wire (red) 
(d). 2D cross-sectional images in sagittal plane for one unfractured and fractured side of both study groups 
(yellow line as example for callus length and diameter) (e). Micro-CT-based quantification of the total bone 
volume (f) and bone density (g) of the whole femur in both the fractured side and the control side of both study 
groups. Diameter at the fracture side compared to the diameter at the correspondence level of the unfractured 
side (h). Micro-CT-based quantification of the total callus volume (i), callus density (j), callus length (k) and 
callus diameter (l) in the fractured side of both study groups. Significance: *p < 0.05, **p < 0.01, ***p < 0.005.
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documented in the existing literature, and the influence of NK1-receptor blockage on the complex, multifactorial 
process of fracture healing cannot be simulated in an in vitro experiment.
Moreover, the volume measurements conducted using µCT analyses might be inaccurate due to obscuring 
by the intramedullary Kirschner wire, which in turn would reduce the volume measurement in the fractured 
bones. Therefore, the segmentation of the bone, the K-wire and the fracture callus regions was performed 
with a very advanced interactive method (Software Imalytics Preclinical) to minimize the error range. Even 
if we had removed the K-wire shortly before the µCT analysis, this removal would have left an empty space, 
which would not be filled with new callus tissue and therefore would probably lead to the same results. 
Conversely, our histology findings concerning trabecular and callus dimensions conform to our µCT find-
ings, indicating that these results are probably reliable. Another possible limitation, was that we did not follow 
up the blocking capacity of SR130444 after finishing the administration after two weeks of fracture healing. 
We assume that the effect of SR130444 is depleted >24 hours after application, but we did not verified it with 
immuno-histological tests.
In conclusion, our study findings show that blocking the NK1-receptor for substance P suppresses gene 
expression of important proteins in the early phases of fracture healing, decreases the quality of callus 
formed, and lessens the biomechanical strength of bone in the late phases of fracture healing. Therefore, 
based on our results, further research should be focused on the exact mechanism of action of Substance P in 
fracture healing to provide a better understanding of its potential therapeutic relevance in cases of disturbed 
fracture healing.
Figure 4. Biomechanical testing of the femora. Significant decrease in maximal load to failure (Nmax) of the 
femora in the NK1-R group at (a) 6 weeks (*p = 0.029) and (b) 3 months (*p = 0.01) after fracture induction.
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Methods
All methods were performed with the approval of the institutional animal committee and of the regulat-
ing authority (LANUV) North Rhine-Westphalia, Recklinghausen, Germany (AZ 84-02.04.2015.A078). All 
animal experiments were performed in accordance with the guidelines and regulations of the Federation of 
European Laboratory Animal Science Associations (FELASA) and the German Society of Laboratory Animals 
(GV-SOLAS).
Housing. Our study cohort consisted of 72 adult, female Sprague-Dawley rats, weighing approximately 250 g, 
obtained from Harlan Industries (Indianapolis, Indiana, USA). The animals were housed and the experiments 
were performed in facility approved by the Federation of European Laboratory Animal Science Associations 
(FELASA) and the German Society of Laboratory Animals (GV-SOLAS). The animals were housed under con-
ditions of controlled temperature (20 ± 2 °C) and air humidity (45–65%), with a 12 h light-darkness cycle and a 
light intensity of <200 lux. Food and water were offered ad libitum. Prior to study inclusion, all animals were kept 
in groups for one week in the laboratory premises to allow acclimatization. Throughout the entire experiment, all 
animals underwent physical examinations according to a ‘score sheet’ documentation and the ‘Body condition 
scoring’ according to Hickman31 to obtain the general health of the animals.
Because of the protective effects of female hormones in cases of inflammatory stimuli, all animals were con-
firmed to be in the same ‘metestrus’ phase of the menstrual cycle, as this phase is characterized by low estrogen 
and progesterone levels14,32. The menstrual cycle phase was identified by the assessment of vaginal swabs accord-
ing to Marcondes and colleagues33.
Experimental design and power analysis. In all animals an intramedullary pin was inserted and 
a standardized femoral fracture was induced. The animals were then randomly assigned to 2 groups (36 rats/
group), according to their order number (odd or even). The first group underwent a selective blockage of the 
NK1-receptor (NK1-R group). The second group served as the control group and only received vehicle (Control 
group). Depending on the experimental subgroup to which an animal was randomly assigned, the femur was 
harvested and the following analyses were executed at different time points: gene expression analysis, histological 
analyses, micro-CT scanning, and biomechanical testing (Fig. 5).
Our primary outcome parameter was the load to failure of the rat femora; therefore, our power analysis was 
based on an average load to failure of 131.3 ± 4.9 N for normal rat femora, as described by previous studies9,34. 
Our calculation indicated that a minimum of 4 rats per group was needed to achieve a 95% power for detecting a 
difference of 10 N with α = 0.05. Therefore, a sample size of six animals per group was chosen to compensate for 
any potential loss of animals. The power analysis was performed with G*Power. Secondary outcome parameters 
were fold change in gene expression of osteocalcin and collagen 1A2 and 2A1 and callus-volume, -density and 
-diameter in micro-CT-analysis.
Reasons for excluding animals were: death from anaesthetic complications, open fracture, comminuted frac-
ture, implant failure, wound dehiscence or infection, gross technical failure, inadequate RNA for analysis, and 
unintended displacement of the femur during biomechanical testing.
Anaesthesia and pain management. Thirty minutes preoperatively, the animals received 0.03–0.05 mg/
kg buprenorphine hydrochloride s.c. as pain medication. The operative procedures were performed under 
general anaesthesia induced with ketamine (100 mg/kg i.p.) and xylazine (2%; 10 mg/kg i.p.) and if necessary, 
extended with 2–2.5 Vol.% isoflurane inhalation. The toe pinch reflex was used to assure adequate anaesthe-
sia. Post-operative analgesia was assured with buprenorphine hydrochloride (0.03–0.05 mg/kg s.c.) every 
6 h for the first 24–48 h. Subsequently, buprenorphine hydrochloride was given twice daily during the first 3 
weeks. Furthermore, in the first postoperative week, the drinking water was supplemented with metamizole 
(1 ml/300 ml). The animals were evaluated postoperatively three times per day for signs of acute deterioration.
Figure 5. Subgroup division and time points of analyses. Subdivision of study cohort in two study groups 
(NK1-R group and Control group) and subsequent division of animals according to performed analysis at 
different time points. Every analysis is performed in 6 animals of both study groups at every time point. At DPO 
(days post-operative) 42 both µCT imaging and biomechanical testing was performed in the same animals.
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Standardized femoral fracture. After anaesthesia induction, the animals were placed on a heated pad 
(37 °C) and their eyes were covered with moistening ointment. The right rear leg was shaved, disinfected, and 
draped. Then, a para-patellar incision was made, the patella was everted laterally and a 1.0 mm stainless-steel 
intramedullary Kirschner wire was inserted in a retrograde manner. Its placement was confirmed by fluoroscopy. 
The K-wire was cut flush with the intercondylar notch and the proximal end was bent over the greater trochanter, 
cut, and hidden subcutaneously. The patella was repositioned and the wounds were closed in layers. Fracture 
induction was performed with a blunt guillotine according to the method of Bonnarens and Einhorn35. A fluoro-
scopic evaluation of the fracture site was performed.
Substance P receptor blockage. Substance P activity was blocked through selective blockage of the 
neurokinin-1-tachykinin-receptor (NK1-R) by subcutaneous administration of SR140333 once daily for the first 
14 days, beginning 30 min preoperatively. This period was chosen because it is the most vulnerable period in the 
fracture healing process in rats in terms of gene expression and the influence of cytokines, chemokines, growth 
factors, etc36,37. SR140333 is a non-peptide antagonist of tachykinin NK1 receptors that potently, selectively, and 
competitively inhibits substance P binding to NK1 receptors38. SR140333 was administered at a concentration of 
1 mg/kg dissolved in a vehicle of 10 μl DMSO (dimethyl sulfoxide) and 0.2 ml of sterile water30,39. The animals of 
the control group received the same amount of vehicle for the same period.
Gene expression. The up-regulation of most genes associated with fracture healing in rats takes place in 
the first two weeks after fracture induction36,37; therefore, gene expression was measured at 3, 7, and 14 days 
post-operative (DPO).
At each time point, 6 animals from each group (NK1-R group and control group) were euthanized with an 
overdose isoflurane and subsequent cervical dislocation. The intramedullary K-wire was removed and bone and 
callus at 0.5 cm on each side of the fracture was harvested, frozen in liquid nitrogen, pulverized, and used for RNA 
extraction. The fold changes of osteocalcin, collagen 1A2, and collagen 2A1 mRNA expression were determined 
by the reverse transcription polymerase chain reaction (RT-PCR). The cDNA was transcribed from total RNA 
using a Maxima H Minus cDNA synthesis kit (Thermo Scientific, US). Real-time quantitative RT-PCR was per-
formed with Power SYBR Green Master Mix (Applied Biosystems, US) using the StepOnePlus™ Real-Time PCR 
System (Invitrogen, CA, USA). The 2−ΔΔCT method (a method to analyse the relative changes in gene expression 
from real-time qPCR experiments) was used to calculate gene expression with peptidylprolyl cis-trans isomerase 
(PPIA) as an internal housekeeping gene reference. The NK1-R and Control groups were compared for their 
expression of collagen-1A2, collagen-2A1, and osteocalcin mRNA.
Histological analysis. At DPO 28, 10 animals underwent histological analysis (6 of the αNK1-R group 
and 4 of the Control group, due to drop out of 2 animals, see Results section). The animals were euthanized, 
the Kirschner wire was removed, and the femora were harvested and fixed in 4% neutral buffered formalin for 
48 hours. Decalcification was performed with ethylenediaminetetraacetic acid (EDTA) and dehydration with 
alcohol. The tissue was embedded in paraffin and 10μm sagittal sections of the callus area and the surrounding 
soft tissues were cut. The sections were stained with haematoxylin eosin (HE) and assessed with an Olympus BHS 
System Microscope. Images were viewed at 40× and 200× magnification, and measurements of the bone were 
performed.
Micro-computed tomography (μCT). Micro-CT imaging was obtained at DPO 42 in 6 euthanized 
animals from each group using a dual-energy gantry-based flat-panel microcomputed tomography scanner 
(TomoScope 30 s Duo, CT Imaging, Erlangen, Germany). The dual-energy X-ray tubes of the μCT were operated 
at voltages of 40 and 65 kV, with currents of 1.0 and 0.5 mA, respectively. Coverage of the entire leg of the rats was 
achieved by performing three sub-scans; each sub-scan acquired 720 projections with 1,032 × 1,012 pixels during 
one full rotation, with durations of 90 s. After acquisition, volumetric data sets were reconstructed using a modi-
fied Feldkamp algorithm with a smooth kernel at an isotropic voxel size of 35 μm. The bone, K-wire, and fracture 
callus regions were segmented using an automated segmentation method with interactive correction of segmen-
tation errors (Software Imalytics Preclinical40). (Fig. 2) The total bone volume, callus volume, bone density, callus 
density, and transverse diameter of the fracture callus were analysed quantitatively. The mid-part of the femoral 
shaft of the unfractured side of the animals from the Control group were taken for reference.
Biomechanical testing. Biomechanical testing was performed at two time points in the healing process to 
analyse the strength of the callus and/or newly formed bone. The first test was performed at DPO 42 in 6 animals 
of both groups; the second test was performed at DPO 84 in 6 animals of both groups. These time points were 
chosen because normal callus formation is completed after 6 weeks and the remodelling process is advanced or 
completed after 3 months. The fractured right as well as the unfractured left femur were tested in all animals. 
After euthanizing the animals and removing the K-wires, both ends of the femora were embedded, closely to 
the callus/fracture site in a two-component resin (Technovit® 3040 powder + Technovit® Universal Liquid)41,42, 
which quickly hardens at low temperature. The embedded femora were tested in the biomechanical testing device 
(Retroline from Zwick Roell AG, Germany), over two cardan yokes, by which the force was conducted perpen-
dicular to the femur axis. The biomechanical traction test was performed with a traction rate of 1 mm/s = 0.1 N/s 
and a measurement interval of 0.1 s. Digital set-up and control was performed using TestXpert II software (Zwick 
Roell AG, Germany), which enabled real-time measurement of the traction force. The obtained parameters were 
used for the calculation of average load to failure in Newton (N).
Data analysis. The data were analysed using the Statistical Package for the Social Sciences (SPSS; version 22; 
IBM Inc., Somers, NY, USA) and GraphPad Prism 5.0 (San Diego, CA, USA). Continuous data are presented as 
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mean ± standard deviation, while incidences are presented as counts and percentages. Differences between the 
groups were evaluated with a two-tailed unpaired Student’s t-test and with analysis of variance (ANOVA with post 
hoc Tukey) for continuous data. In general, Pearson’s χ2-test was used for categorical values. The gene expression 
and biomechanics data were analysed with the Mann–Whitney U test as a non-parametrical test. Potential statis-
tical associations were evaluated with Pearson’s correlation. In general, a two sided p-value < 0.05 was considered 
statistically significant.
Proofreading. Scribendi Inc. (Chatham, Ontario N7M 0N3 Canada) performed the proofreading of our 
manuscript.
Data Availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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